SK Biopharmaceuticals Co., Ltd.

KRX:326030.KS

110300 (KRW) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

2023202220212020201920182017201620152014201320122011
Operating Activities:
Net Income -32,882.849-139,430.87864,845.64-247,413.614-71,519.467-138,096.479-97,649.06-30,360.843-28,061.186-37,048.875-41,001.914-30,330.598-19,465.137
Depreciation & Amortization 15,317.44412,983.73811,641.82810,858.7176,500.9223,342.2993,165.1223,085.0844,567.2094,340.5295,249.3655,758.9355,173.531
Deferred Income Tax 0045,851.33000198.7670-3,880.8324,256.5055,722.44800
Stock Based Compensation 060.663416.71300000-2,496.0931,277.8031,218.28900
Change In Working Capital -75,642.763-65,664.207-69,712.93320,724.602-6,878.384-8,376.416-6,200.0542,691.6763,284.797-9,689.944-7,964.974-4,134.736-2,072.246
Accounts Receivables -53,577.334-12,387.85-38,187.477-11,241.261-110.79214,365.397-14,267.224000000
Inventory -13,707.882-38,692.989-29,459.21-16,629.756-6,733.3290-22.179-1,451.197-5,311.683-3,595.679-1,947.5341,017.4866,229.524
Accounts Payables -20,710.616,965.1607.6878,960.976110.792-24,470.3147,821.39000000
Other Working Capital 12,353.063-21,548.468-2,673.93339,634.643-145.0551,728.501-6,177.8754,142.8738,596.48-6,094.265-6,017.44-5,152.222-8,301.77
Other Non Cash Items -993.08132,130.622-145,914.3115,104.286-9,437.7431,849.1972,341.262-24,357.169-2,130.587-3,472.414-2,287.654,641.356-598.737
Operating Cash Flow -94,201.249-159,920.062-92,871.733-210,726.009-81,334.672-141,281.399-98,342.73-48,941.252-28,716.692-40,336.396-39,064.436-24,065.043-16,962.589
Investing Activities:
Investments In Property Plant And Equipment -3,249.365-5,960.948-5,991.9-14,336.495-14,048.175-1,435.935-1,646.351-8,803.581-3,838.181-2,877.205-4,866.572-1,226.95-1,570.786
Acquisitions Net 31,043.4274,232.99548,721.684-3,313.8062,342.8071,580.806-74.333101,211.82130.67327149.90708.74
Purchases Of Investments -106,412.825-458,344.149-174,035.996-303,721.543-29,012.279-0.157-14.475-82,997.44-26.535-61,493.333-4,429.396-64.435-94,056.342
Sales Maturities Of Investments 305,000364,419.719390,932.46242.128472.44237,106.55190,009.163-19.65572,550.666539.49240,167.62514,001.66,451.241
Other Investing Activites -1,108.647-61.423-654.7562,599.57779.7422,206.527123.7968,979.267-1,148.863,851.777929.05911,480.6892,007.481
Investing Cash Flow 225,272.591-95,713.806258,971.494-318,730.147-39,465.46339,457.94988,397.818,370.41267,667.763-59,952.26931,950.62324,190.904-87,159.666
Financing Activities:
Debt Repayment 0141,751.150-4,562.175-2,759.4280000000-35,428.8
Common Stock Issued 000645,464.6690149,960.36500099,973.365000
Common Stock Repurchased 0000000000000
Dividends Paid 0000000000000
Other Financing Activities 6,622.756-6,836.888-4,645.85-100,000100,0000-0000000
Financing Cash Flow 6,622.756134,914.263-4,645.85540,902.49497,240.572149,960.365-00099,973.3650-1,239.568-35,428.8
Other Information:
Effect Of Forex Changes On Cash -2,053.757-1,142.9715,135.128-3,254.049408.328883.456-3,397.209617.8271,383.612356.98-440.645-806.912491.538
Net Change In Cash 135,640.34-121,862.576166,589.048,192.29-23,151.23449,020.371-13,342.14-29,953.01240,334.68241.681-7,554.458-681.052-139,059.517
Cash At End Of Period 239,700.042104,059.703225,922.27859,333.23951,140.94874,292.18225,271.81138,613.95168,566.96328,232.28128,190.60135,745.05936,426.11